Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology


Helix Biopharma to Present L-DOS47 Lung Cancer Research Findings at the Fourth International Conference on Tumor Microenvironment in Florence, Italy

- Helix BioPharma Corp. (TSX: HBP /Frankfurt: WKN918864) AURORA, ON, March 5 /CNW/Dr. Heman Chao, Vice President of Researchat Helix BioPharma Corp., a developer of novel cancer therapeutics,will be presenting a scientific poster at the Fourth InternationalConference on Tumor Microenvironment, which runs from March 6th to10th in Florence, Italy. The conference, hosted by the...

Replidyne Phase II Pediatric Trial Meets Primary Objective

LOUISVILLE, Colo., March 06, 2007 /PRNewswire-FirstCall/ --Replidyne, Inc. announced today that it has completed its Phase IIclinical trial using faropenem medoxomil (faropenem) in pediatricpatients with acute otitis media (AOM), a common infection of themiddle ear. Initial analyses of the study results show that it metits primary objective to show that faropenem was effective ineradicatin...

DVT Awareness Survey Findings: Heart and Respiratory Patients

WASHINGTON, March 06, 2007 /PRNewswire/ -- Up to two millionAmericans are affected each year by DVT, with up to 600,000hospitalized. Its primary complication, pulmonary embolism (PE),claims up to 300,000 lives annually -- more than breast cancer andAIDS combined. People who suffer from cardiovascular disease may beat increased risk for DVT, because these factors also heighten thelikelihood...

Pozen Announces Positive Outcome for PA 325

Chapel Hill, N.C., March 6, 2007-Pozen Inc. (NASDAQ: POZN),today announced top-line results of its "Safer Aspirin" PA 325proof-of-concept study conducted during the fourth quarter of 2006.PA 325 is a patented formulation of 325mg of aspirin surrounded bya 20mg coating of an immediate release formulation of a proton pumpinhibitor. The PA 325, 28 day study, involved two groups of 40 subject...

Advanced Magnetics Announces Presentation of Ferumoxytol Data at the National Kidney Foundation 2007 Spring Clinical Meetings

CAMBRIDGE, Mass., March 06, 2007 /PRNewswire-FirstCall/ --Advanced Magnetics today announced that data from three completedPhase III multi- center clinical studies of ferumoxytol as anintravenous iron replacement therapeutic will be presented duringthe National Kidney Foundation (NKF) 2007 Spring Clinical Meetingstaking place April 10th through 14th in Orlando, Florida. Twoposters containi...

POZEN Announces Positive Outcome for PA 325 Proof of Concept Study

CHAPEL HILL, N.C.--(BUSINESS WIRE)--Mar 6, 2007 - POZEN Inc.(NASDAQ: POZN), today announced top-line results of its "SaferAspirin" PA 325 proof-of-concept study conducted during the fourthquarter of 2006. PA 325 is a patented formulation of 325mg ofaspirin surrounded by a 20mg coating of an immediate releaseformulation of a proton pump inhibitor. The PA 325, 28 day study, involved two group...

Nventa Announces Presentation of Positive HspE7 Data from NCI-Sponsored Clinical Trial in Cervical Dysplasia

- 78 Percent of Patients Showed Complete Response or Reduction ofLesion Size by More than Fifty Percent - SAN DIEGO, CA, March 05, 2007 /PRNewswire-FirstCall/ - NventaBiopharmaceuticals Corporation today announced the presentation ofpositive results from a clinical trial examining the safety andefficacy of pilot process HspE7, an investigational therapeuticvaccine for human papillomavirus (...

AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II Study with Novel Cystic Fibrosis Therapy

VIENNA, Austria and CHAPEL HILL, N.C., US, March 06, 2007/PRNewswire/ -- AOP Orphan Pharmaceuticals AG ("AOP Orphan") andLantibio, Inc. ("Lantibio") today announced positive final resultsfrom their placebo controlled, double-blinded Phase II clinicalstudy of Moli1901, an experimental compound to treat cysticfibrosis ("CF"). Moli1901 is being developed by AOP Orphan inEurope under a licensi...

Advanced Cell Technology's Ability to Rescue Vision in Blind Rats Noted in Scientific American

ALAMEDA, Calif.--(BUSINESS WIRE)--Mar 5, 2007 - Advanced CellTechnology, Inc.'s (OTCBB: ACTC) ability to rescue vision in blindrats was noted in Scientific American's March 2007 issue as thelead story of its News Scan section. The full text of the article,which notes Advanced Cell's ability to "coax embryonic stem cellsto turn into transplantable retinal pigment epithelial (RPE)tissue," is...

Accentia Biopharmaceuticals Scientific Presentations Demonstrate Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at the Annual Meeting of the American Academy of Allergy, Asthma, and Immunology

TAMPA, Fla.--(BUSINESS WIRE)--Mar 7, 2007 - AccentiaBiopharmaceuticals, Inc. (NASDAQ: ABPI), presented three posters atthe Annual Meeting of the American Academy of Allergy, Asthma, andImmunology from February 23 - 27, 2007 in San Diego, CA. Theposters discussed findings from a survey of 202 otolaryngologists(ENTs) and allergists in the U.S., U.K., France, and Germany on theburden of chroni...
[next]
(Date:8/15/2019)... ... 15, 2019 , ... With many students either starting college for the first time, and returning ... to the CDC , “there are about 20 million new cases of STDs each ... ages of 15 and 24. Young people are at greater risk of getting an STD.” ...
(Date:8/14/2019)... FORT LAUDERDALE, Fla. (PRWEB) , ... August 14, ... ... for medical scribe and Care Team Assistant support, has earned a place on ... 3,164, this year’s Inc. 500|5000 inclusion marks nearly a decade of ScribeAmerica’s recognition ...
(Date:8/14/2019)... ... August 13, 2019 , ... New U Life Corporation® ... president of operations and information technology, and Elie Goldstein, vice president of product development ... New U Life’s commitment to expanding its corporate governance. , “Since founding New U ...
(Date:8/12/2019)... , ... August 12, 2019 , ... Parents craving a ... only nourish their families but also help feed children in need. IsaKids® Super Smoothie ... 2019 event in Nashville, Tennessee. The global health and wellness company also debuted Organic ...
(Date:8/9/2019)... ... , ... Advanced Clinical, a clinical research services organization, is ... pharmaceutical market with the recent opening of a new, centrally located office in ... thorough coverage of Western Europe. Access to an extensive network of Key Opinion ...
Breaking Medicine News(10 mins):
... , Third Largest Full-Service Lab in US Realizes ROI ... TREVOSE, Pa., June 16 AirClic, a leading mobile ... Laboratories, Inc. (BRLI) the third largest full-service lab in ... AirClic technology within seven months of its deployment. , ...
... Thousands Expected for Healthy Lifestyle Celebration , , Governor Pat ... Vida! Get Up! Get Moving Day! in Chicago and State of ... 60 health and community services agencies will join the Chicago Hispanic ... Get Up! Get Moving! (TM) celebration. The ...
... birth rate , , TUESDAY, June 16 (HealthDay News) -- ... as white women, and a greater likelihood of depression may ... Researchers looked at birth-rate data collected over six years from ... included health information from about 5,000 young adults living in ...
... /PRNewswire-FirstCall/ - Nuvo Research Inc. (TSX: NRI) a Canadian ... of drug products delivered to and through the skin ... announced that it has entered into a license and ... (NYSE: COV ), a leading global provider of ...
... Receptor Mutation Test May Be Key To Identifying Patient ... Calif., June 16 Clarient, Inc. (Nasdaq: ... services resource for pathologists, oncologists, and the pharmaceutical industry, ... test that can help physicians select the proper therapy ...
... ... online. A new poll of over 4,800 health consumers from eHealthForum.com reveals ... prefer to rely on patient-only or patient-doctor opinion 63% of the time. ... in order to provide effective, timely and potentially life-saving services. , ...
Cached Medicine News:
The 14D provides high magnification along with an optimized working distance from the cornea. With its 4.30x magnification, it is also well suited for optic disc and macular observation....
The Professional ophthalmoscope has been designed to ensure ultimate control. Lenses, graticules and filters can all be introduced at the touch of a fingertip without the need to pull away from the p...
The Professional ophthalmoscope has been designed to ensure ultimate control. Lenses, graticules and filters can all be introduced at the touch of a fingertip without the need to pull away from the p...
... This ELISA is based on the C6 peptide ... surface protein VlsE. This peptide has been ... containing substantially all of the antigenic reactivity of ... that the C6 peptide is a sensitive and ...
Medicine Products:
(Date:8/16/2019)... ... August 16, 2019 , ... Inc. magazine today revealed that ... most prestigious ranking of the nation’s fastest-growing private companies. The list represents a ... segment—its independent small businesses. Microsoft, Dell, Domino’s Pizza, Pandora, Timberland, LinkedIn, Yelp, Zillow, ...
(Date:8/15/2019)... ... August 15, 2019 , ... Inc. ... the most prestigious ranking of the nation’s fastest-growing private companies. The list represents ... dynamic segment—its independent small businesses. Microsoft, Dell, Domino’s Pizza, Pandora, Timberland, LinkedIn, Yelp, ...
(Date:8/14/2019)... ... August 14, 2019 , ... ... and addition of 5,217 sf. With pet care at the forefront of design, ... medicine, cardiology, endoscopy and CT. Twelve exam rooms, office space and a dedicated ...
Breaking Medicine Technology:
... PALO ALTO, Calif.--(BUSINESS WIRE)--Apr 12, 2007 - ... from its Phase,2 clinical trial of Hematide(TM) ... week at the National Kidney Foundation (NKF),2007 ... trial in patients previously treated with,three-times weekly ...
... 2007--The costs of eradicating,poliomyelitis from the remaining infected ... lower than the long term costs of trying,to ... vaccine is almost three times more effective against,type ... are,the findings of two Articles published Online and ...
Cached Medicine Technology: